Literature DB >> 20622816

Sequencing firms vie for diagnostics market, tiptoe round patents.

Michael Eisenstein.   

Abstract

Mesh：

Year:  2010        PMID： 20622816     DOI： 10.1038/nbt0710-635a

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

1.  Sitting up and taking notice.

Authors: 
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

2.  Diagnostics firms face new patent claim worries.

Authors:  Malorye Allison
Journal:  Nat Biotechnol       Date:  2009-07       Impact factor: 54.908

3.  Genetics. Trends in human gene patent litigation.

Authors:  Christopher M Holman
Journal:  Science       Date:  2008-10-10       Impact factor: 47.728

4.  Legal uncertainty in the area of genetic diagnostic testing.

Authors:  Isabelle Huys; Nele Berthels; Gert Matthijs; Geertrui Van Overwalle
Journal:  Nat Biotechnol       Date:  2009-10       Impact factor: 54.908

5.  Development of personalized tumor biomarkers using massively parallel sequencing.

Authors:  Rebecca J Leary; Isaac Kinde; Frank Diehl; Kerstin Schmidt; Chris Clouser; Cisilya Duncan; Alena Antipova; Clarence Lee; Kevin McKernan; Francisco M De La Vega; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz; Victor E Velculescu
Journal:  Sci Transl Med       Date:  2010-02-24       Impact factor: 17.956
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.